zerohedge.com / by Tyler Durden on 03/25/2014 12:43 -0400
UPDATE: Sure enough the 100DMA was met with buying… for now…
The Nasdaq Biotech index is down 4% from earlier opening highs and is once again testing the 100-day-moving-average that provided some impetus for a modest bounce yesterday. This is a 10-week low level (-14% from Feb highs) and has retraced over 60% of the gains since the Fed announced the taper in December. Volume has been very heavy.
The post Nasdaq Biotech Index Re-Plunges To 10-Week Lows appeared first on Silver For The People.
